Goldman Sachs says these blue chip ASX 200 shares are top buys

These shares could be in the buy zone according to the broker.

| More on:
A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Owning a few blue chip ASX 200 shares can be a good way of ensuring you have a rock-solid investment portfolio.

But deciding which blue chips to buy over others is not easy. But don't worry, because analysts at Goldman Sachs have done the hard work for you.

Listed below are three blue chips that the broker rates very highly right now. Here's what you need to know about them:

Endeavour Group Ltd (ASX: EDV)

The first blue chip ASX 200 share that Goldman Sachs has named as a buy is Endeavour.

It is the drinks giant behind the BWS and Dan Murphy's brands, as well as a large network of hotels.

Goldman believes Endeavour's shares are good value based on its leadership position and positive outlook. It explains:

Most attractive valuation amongst Staples peers: We continue to see defensiveness in the company's Retail business with relative market share of ~35% vs COL liquor of ~13%, 5.2mn active My Dan's members. EDV is currently trading at FY24e P/E of 18.4x with FY23-25e EPS CAGR of ~5%, which is the cheapest vs WOW, COL, WES.

Goldman has a conviction buy rating and $6.40 price target on the company's shares.

ResMed Inc. (ASX: RMD)

Another blue chip ASX 200 share that Goldman Sachs rates as a buy is ResMed.

It is a sleep treatment company with a portfolio of leading hardware and digital solutions for disorders such as sleep apnoea.

Goldman Sachs believes the risk/reward is very attractive for investors at current prices. It said:

We view the risk/reward to be favorable and are Buy-rated. We view valuation as attractive and see a favourable risk-reward skew post the recent de-rate, noting the shares are trading meaningfully below historical averages on both a P/E and EV/EBITDA basis.

The broker has a buy rating and $32.00 price target on the company's shares.

Woolworths Limited (ASX: WOW)

Finally, Australia's largest supermarket operator could a blue chip ASX 200 share to buy according to Goldman.

Its analysts like Woolworths due to potential market share gains thanks to the strength of its loyalty program and its omni-channel advantage. The broker said:

We are Buy rated (on Conviction List) on the stock as we believe the business has among the highest consumer stickiness and loyalty among peers, and hence has strong ability to drive market share gains via its omni-channel advantage, as well as pass through any cost inflation to protect its margins, beyond market expectations.

Goldman has a buy rating and $42.40 price target on its shares.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the 'five best ASX stocks' for investors to buy right now. We believe these stocks are trading at attractive prices and Scott thinks they could be great buys right now...

See The 5 Stocks *Returns as of 9 January 2025

Motley Fool contributor James Mickleboro has positions in Endeavour Group and ResMed. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group and ResMed. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Blue Chip Shares

A man is shocked about the explosion happening out of his brain.
Blue Chip Shares

3 no-brainer ASX 200 blue chip stocks to buy this month

Analysts think these stocks are high quality options for blue chip investors.

Read more »

Man pointing an upward line on a bar graph symbolising a rising share price.
Blue Chip Shares

These ASX 200 blue chip shares could rise 30% in 2025

Brokers think these blue chips could be market-beaters in 2025. Let's find out why.

Read more »

Blue Chip Shares

Buy Woolworths, ResMed, and this ASX 200 share in January

Analysts think the supermarket giant and these shares are in the buy zone this month.

Read more »

Blue Chip Shares

Analysts say these ASX 200 blue chip shares are top buys in January

These blue chips have been named as buys by analysts.

Read more »

Business people discussing project on digital tablet.
Blue Chip Shares

Are these the best ASX 200 blue chip shares to buy in 2025?

Analysts at Bell Potter have good things to say about these stocks.

Read more »

A young man punches the air in delight as he reacts to great news on his mobile phone.
Blue Chip Shares

4 excellent ASX 200 blue chip shares to buy in 2025

If you are in the process of building an investment portfolio, then having a few ASX 200 blue chip shares in there…

Read more »

A couple makes silly chip moustache faces and take a selfie on their phone.
Blue Chip Shares

I think these are the 3 best ASX blue-chip shares for dividends

There are only a few big companies I’d want to own.

Read more »

A happy older couple relax in a hammock together as they think about enjoying life with a passive income stream.
Blue Chip Shares

Buy these quality ASX blue chip shares for a passive income boost

Analysts think these blue chips could be great options for investors searching for passive income.

Read more »